Light Mode
$14.87 ↑ +0.00 (+0.00%) Trading Up from the previous close of $14.87, $1.30 below the day’s high of $16.17
-15.12 (-50.42%) / 6M
Momentum, market sentiment, and recent alerts
AVBP reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -15.5%.
No alerts for AVBP in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, licensing, and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.